Abstract
Two cases of acute valproic acid poisoning with central nervous system depression and raised ammonia level without hepatotoxicity were reported. They were treated successfully with the use of the antidotes:
1.
1
Watson WA
Litovitz TL
Rodgers QC
Klein-Schwartz V
Reid N
Youniss J
. 2004 Annual Report of the American Association of Poison Control Centers Toxic Exposure Surveillance System.
Am J Emerg Med
2005 ; 23 : 589 – 666 .
2.
2
Sztajnkrycer MD
. Valproic acid toxicity: overview and management.
J Toxicol Clin Toxicol
2002 ; 40 : 789 – 801 .
3.
3
Raskind JY
El-Chaar GM
. The role of carnitine supplementation during valproic acid therapy.
Ann Pharmacother
2000 ; 34 : 630 – 638 .
4.
4
Verrotti A
Trotta D
Morgese G
Chiarelli F
. Valproate-induced hyperammonemic encephalopathy.
Metab Brain Dis
2002 ; 17 : 367 – 373 .
5.
5
Barrueto F
Hack JB
. Hyperammonemia and coma without hepatic dysfunction induced by valproate therapy.
Acad Emerg Med
2001 ; 8 : 999 – 1001 .
6.
6
Bohnan TP
Helton E
McDonald I
König S
Gazitt S
Sugimoto T
. Effect of l-carnitine treatment for valproate-induced hepatotoxicity.
Neurology
2001 ; 56 : 1405 – 1409 .
7.
8.
8
LoVecchio F
Shriki J
Samaddar R
. l-Carnitine was safely administered in the setting of valproate toxicity.
Am J Emerg Med
2005 ; 23 : 321 – 322 .